Efalizumab |
Efalizumab Products |
| Long-term efalizumab effective in severe psoriasis.(Clinical Rounds): An article from: Internal Medicine News Jeff Evans International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Weekly Efalizumab Achieves Psoriasis Turnaround.(Brief Article): An article from: Skin & Allergy News Betsy Bates International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Efalizumab effective for recalcitrant psoriasis in large study.(Dermatologic Therapy): An article from: Skin & Allergy News Kate Johnson International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Efalizumab makes bid for psoriasis Tx approval. (Application Filed with FDA).: An article from: Skin & Allergy News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Panel unanimously backs efalizumab for adult psoriasis: biologic therapy: the FDA advisory panel recommended further studies to assess long-term safety.: An article from: Skin & Allergy News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Avoid psoriasis rebound with efalizumab therapy.(Dermatologic Therapy): An article from: Skin & Allergy News Kate Johnson International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Rebound of psoriasis during treatment with efalizumab.(CASE REPORTS): An article from: Journal of Drugs in Dermatology Nicholas Golda, Shahrad M. Benham, John Koo Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Long-term efalizumab helps maintain gains of psoriasis therapy. (Good Compliance).(Xanelim tested by Genentech Inc.): An article from: Skin & Allergy News Norra MacReady International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Psoriasis: expert offers pearls on efalizumab use.(Dermatologic Therapy): An article from: Skin & Allergy News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Efalizumab's rapid action promising for psoriasis. (Long-Term Maintenance).(Efalizumab is likely to be next biologic agent approved to treat psoriasis): An article from: Skin & Allergy News Bruce Jancin International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Efalizumab may be next biologic agent for psoriasis: FDA advisory panel gives ok.(Rx): An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Efalizumab likely to be next biologic treatment for psorasis: FDA advisory panel gives ok.(Rx): An article from: Family Practice News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 


